I bio, inc. – product pipeline review – 2012


Published on

2012 Aarkstore.com | iBio, Inc. – Product Pipeline Review – 2012

Published in: Business, Technology
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

I bio, inc. – product pipeline review – 2012

  1. 1. Aarkstore.com announces, The Latest market research report is available inits vast collection:iBio, Inc. – Product Pipeline Review – 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s pharmaceuticals report, “iBio, Inc. - Product Pipeline Review- 2012” provides data on the iBio, Inc.’s research and development focus. The reportincludes information on current developmental pipeline, complete with latestupdates, and features on discontinued and dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, iBio, Inc.’s corporate website, SEC filings, investorpresentations and featured press releases, both from iBio, Inc. and industry-specificthird party sources, put together by Global Markets Direct’s team.Scope- iBio, Inc. - Brief iBio, Inc. overview including business description, key informationand facts, and its locations and subsidiaries.- Review of current pipeline of iBio, Inc. human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Table of contents:List of Tables 5
  2. 2. List of Figures 5iBio, Inc. Snapshot 6iBio, Inc. Overview 6Key Information 6Key Facts 6iBio, Inc. – Research and Development Overview 7Key Therapeutic Areas 7iBio, Inc. – Pipeline Review 10Pipeline Products by Stage of Development 10Pipeline Products – Monotherapy 11iBio, Inc. – Pipeline Products Glance 12iBio, Inc. Clinical Stage Pipeline Products 12Phase I Products/Combination Treatment Modalities 12iBio, Inc. – Early Stage Pipeline Products 13Pre-Clinical Products/Combination Treatment Modalities 13iBio, Inc. – Drug Profiles 14Alpha-1 Antitrypsin 14Product Description 14Mechanism of Action 14R&D Progress 14Anthrax Monoclonal Antibody 15Product Description 15Mechanism of Action 15R&D Progress 15Anthrax Vaccine 16Product Description 16Mechanism of Action 16R&D Progress 16C1-Esterase Inhibitor 17Product Description 17Mechanism of Action 17R&D Progress 17Growth Factor 18Product Description 18Mechanism of Action 18
  3. 3. R&D Progress 18H1N1 Influenza Vaccine 19Product Description 19Mechanism of Action 19R&D Progress 19H5N1 Avian Influenza Vaccine 21Product Description 21Mechanism of Action 21R&D Progress 21HPV Vaccine 23Product Description 23Mechanism of Action 23List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=Product PipelineReview – 2012&PubId=&pagenum=1Genta Incorporated – Product Pipeline Review – 2012Geron Corporation – Product Pipeline Review – 2012Glenmark Pharmaceuticals Ltd. – Product Pipeline Review – 2012
  4. 4. iBio, Inc. – Product Pipeline Review – 2012ImmunoGen, Inc. – Product Pipeline Review – 2012Can-Fite BioPharma Ltd. – Product Pipeline Review – 2012Celtic Biotech, Ltd. – Product Pipeline Review – 2012Cyclacel Pharmaceuticals Inc. – Product Pipeline Review – 2012Endocyte, Inc. – Product Pipeline Review – 2012Flamel Technologies S.A. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com